Related references
Note: Only part of the references are listed.ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
Paul G. Kemps et al.
BLOOD (2022)
A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome
Ekin Guney et al.
BLOOD ADVANCES (2022)
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Elias Campo et al.
BLOOD (2022)
Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma
Jacob D. Soumerai et al.
BLOOD (2022)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Rita Alaggio et al.
LEUKEMIA (2022)
Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition
Ashiq Masood et al.
NPJ GENOMIC MEDICINE (2021)
Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK plus LBCL): a systematic review of clinicopathological features and management
Jorge J. Castillo et al.
LEUKEMIA & LYMPHOMA (2021)
A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis
Alexandra Butzmann et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2020)
ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma
Jen-Chieh Lee et al.
JOURNAL OF PATHOLOGY (2017)
Anaplastic lymphoma kinase protein positive diffuse large B cell lymphoma; A developing world experience
Huzaifah Salat et al.
PATHOLOGY RESEARCH AND PRACTICE (2017)
Anaplastic lymphoma kinase-positive large B-cell lymphoma: Clinico-pathological study of 17 cases with review of literature
Xiang-Nan Jiang et al.
PLOS ONE (2017)
Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technology
Adriane F. Evangelista et al.
BMC PULMONARY MEDICINE (2017)
ALK-positive Large B-cell Lymphoma A Clinicopathologic Study of 26 Cases With Review of Additional 108 Cases in the Literature
Zenggang Pan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
The role of the ALK receptor in cancer biology
B. Hallberg et al.
ANNALS OF ONCOLOGY (2016)
Identification of Oncogenic Mutations and Gene Fusions in the Follicular Variant of Papillary Thyroid Carcinoma
David G. McFadden et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
Christine M. Lovly et al.
CANCER DISCOVERY (2014)
TFG-1 function in protein secretion and oncogenesis
Kristen Witte et al.
NATURE CELL BIOLOGY (2011)
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer
Klarisa Rikova et al.
CELL (2007)
Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells
F Armstrong et al.
ONCOGENE (2004)
ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements:: report of 6 cases
RD Gascoyne et al.
BLOOD (2003)
Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas -: Identification of a new TFG-ALKXL chimeric gene with transforming activity
L Hernández et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas
HG Drexler et al.
LEUKEMIA (2000)
Share Paper
